Skip to content

SCHEDULE 13D/AAccepted Mar 12, 9:11 PM ET

Outlook Therapeutics, Inc. SCHEDULE 13D/A

GMS Ventures & Investments

Accepted (ET)

9:11 PM

Mar 12, 2025

Filed

Mar 12, 2025

Documents

2

Size

19.9 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.